Market Place
Sourcing Support
Padagis` Generic Halobetasol Propionate Receives Approval in the U.S.
11 Aug 2023 //
FDA
Padagis` Generic Halobetasol Propionate Receives Approval in the U.S.
17 Oct 2022 //
FDA
Enforcement Report - Week of May 11, 2022
11 May 2022 //
PRESS RELEASE
Enforcement Report - Week of March 30, 2022
30 Mar 2022 //
FDA
Enforcement Report - Week of January 26, 2022
26 Jan 2022 //
FDA
Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology
19 Oct 2021 //
PRNEWSWIRE
FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
21 Sep 2021 //
PRNEWSWIRE
Perrigo Israel`s Generic Halobetasol Propionate Receives Approval in US
09 Jun 2020 //
FDA
Health Canada Issues Recall of Bausch Health Canada `s Ultravate
21 Apr 2020 //
FDA
FDA approves trade name Lexette(TM) (halobetasol propionate) foam, 0.05%
30 Apr 2019 //
PRNASIA
Shares of Bausch Health, formerly Valeant, rise 3% on FDA approval of psoriasis
26 Apr 2019 //
CNBC
Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in US
13 Feb 2019 //
PR NEWSWIRE
Mayne Pharma launches anti-plaque psoriasis agent in US
13 Feb 2019 //
BIOSPECTRUM
Perrigo` Generic Halobetasol Propionate Receives Tentative Approval in US
21 Nov 2018 //
FDA
Cosmo to give Bausch Health a run for its money with FDA nod for Xifaxan rival
21 Nov 2018 //
FIERCE PHARMA
Bausch revives FDA quest for psoriasis hopeful Duobrii
31 Aug 2018 //
FIERCE PHARMA
US FDA rejects Valeant’s Duobrii for plaque psoriasis
19 Jun 2018 //
IN PHARMATECHNOLOGY
FDA rejects Duobrii, a Valeant `Significant Seven` drug
19 Jun 2018 //
FIERCE PHARMA
Valeant nosedives on CRL for plaque psoriasis, raising concerns over touted $1B
18 Jun 2018 //
ENDPTS
Perrigo Confirms First To File Patent Challenge For Generic Version Of Ultravate
14 May 2018 //
PR NEWSWIRE
Ultravate® (Halobetasol Propionate) : Sun Pharmaceutical v. Perrigo Company
09 May 2018 //
PATENT LITIGATION
Teligent, Inc. Announces FDA Approval of Halobetasol Propionate Ointment, 0.05%
21 Mar 2018 //
GLOBE NEWSWIRE
Valeant Pharmaceuticals Posts Phase 3 Results for Psoriasis Treatment
13 Dec 2016 //
DDDMAG
Ferndale Labs` Ultravate approved in US for dermatological use
09 Nov 2015 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.